“Harini leads Real World Evidence and Insights- Technology Product
in Sanofi and oversaw the implementation of Sanofi’s RWE Strategy into an end to end big data analytics platform on the cloud. She has a diverse experience that combines research informatics, Real world evidence analytics and big data technologies and has worked across several life science customers in her past life. She has a Master’s in Bioinformatics and an engineering in Computer Science.”
May 26, 2021 11:30 AM PT
Gaining insights and knowledge from real-world health data (RWD), i.e., data acquired outside the context of randomized clinical trials, has been an area of continued opportunity for pharma organizations.
What is real-world data and real-world evidence - how it is generated, what value it drives for life sciences in general and what kind of analytics are performed.
What are some considerations and challenges related to data security, privacy, and industrialization of a big data platform hosted in the cloud.
How we leveraged Databricks to perform big data ingestion - advantages over native AWS Batch/Glue Examples of some of the advanced analytics use cases downstream that leveraged DB for RWE.
Note: This solution and one of the use case leveraging the solution won the 2020 Gartner Eye for Innovation award.
In this session watch:
Harini Gopalakrishnan, Director, Sanofi
Martin Longpre, Architect, Sanofi